Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan Mulls Importing Enough H1N1 Vaccine To Treat 20 Million

This article was originally published in PharmAsia News

Executive Summary

Japan might import enough H1N1 vaccines to treat as many as 20 million people in advance of epidemics that could break out in the fall or winter. The Health Ministry is trying to work out the proper number of doses, fearing it could need enough for 53 million if the government is to cover most elderly people. The ministry expects to make its decision by the end of July on how many of the elderly are to be given priority for vaccinations. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072157

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel